# China Registry for Genetic / Metabolic Liver Diseases

> **NCT03131427** · — · RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 20000 (estimated)

## Conditions studied

- Genetic/Metabolic Liver Diseases

## Interventions

- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT03131427
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-06-13
- **Primary completion:** 2022-04-28
- **Final completion:** 2027-04-28
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2017-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131427, "China Registry for Genetic / Metabolic Liver Diseases". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03131427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*